10Indexed trials
mesh condition
Lung Neoplasms
Intelligence
Lung Neoplasms intelligence: 10 indexed trials, 2 recruiting studies, 10 sponsors across 11 countries.
2Recruiting
10Sponsors
11Countries
Leading sponsors
China Medical University Hospital10 recruiting
GlaxoSmithKline10 recruiting
Incyte Corporation10 recruiting
Lisa Sanderson Cox, PhD10 recruiting
Merck Sharp & Dohme LLC11 recruiting
NeuroVita Clinic10 recruiting
New York State Psychiatric Institute10 recruiting
Ohio State University Comprehensive Cancer Center10 recruiting
The First Affiliated Hospital of Guangzhou Medical University11 recruiting
Universitätsmedizin Mannheim10 recruiting
Geographic activity
United States5trials
Germany1trials
Greece1trials
Hungary1trials
Italy1trials
Chile1trials
Russia1trials
Spain1trials
Turkey (Türkiye)1trials
Ukraine1trials
Poland1trials
Leading interventions
Pemetrexed2trials
Cisplatin2trials
Paclitaxel2trials
Carboplatin2trials
Gemcitabine2trials
Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes1trials
Exposure: psychological stress status1trials
Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes1trials
Epacadostat1trials
Enteral analgesics1trials
Cognitive-behavioral therapy for worry, uncertainty & insomnia1trials
Dinalbuphine sebacate1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.